United Therapeutics Shares Up With Tyvaso Nearing FDA Milestone
United Therapeutics shares gained 1.4% to $576.30 in early-afternoon trade Tuesday. The stock opened at $564.61 and reached as high as $576.99 intraday. Market cap was about $27.2 billion. Nasdaq opened again after the Memorial Day break, pushing broader stock indexes higher in early U.S. trading. Tech stocks took the lead, with the Nasdaq out in front. Growth-focused healthcare shares also got a lift compared to trading before the holiday.